US stocks finished Friday's session with small gains after the previous day's sell-off, as a softer-than-expected inflation print repaired sentiment slightly following fears about an AI bubble earlier ...

European shares closed in negative territory on Friday after another sell-off on Wall Street overnight, driven by renewed jitters around a potential artificial intelligence bubble, as investors ...

UK stock markets ended the week on a positive note after earlier choppy trading on Friday, nearing this week's record high, ...

Sage Group revealed on Friday that non-executive director Jillian Bates, a person closely associated with non-executive director John Bates, had acquired 35,000 ordinary shares in the FTSE 100-listed ...

Miners will be in focus next week, with results due from Rio Tinto, BHP, Antofagasta, Glencore and Anglo American, while UK jobs data, inflation and retail sales figures will also be eyed.

Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D ...

Chemring gained in line with FTSE 100 defence peers BAE Systems and Rolls-Royce.

Car maker Stellantis is reportedly quietly resurrecting diesel versions of at least seven car and passenger van models across ...

Wall Street trading got off to a mixed start on Friday as investors digested some key consumer inflation figures from the ...

Moderna revenues fell by almost a third over the final quarter of 2025, though the American pharma giant reported a narrower loss than expected, causing shares to rise in pre-market trading.

NatWest stretched its outlook for a return on tangible equity - a key industry measure - out to 2028, targeting more than 18% ...

Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D ...